Biomolecular features of ARID1A, HNF1β and ERα in clear cell carcinoma of the ovary

被引：0
|
作者：
Abou-Taleb, H. [1 ]
Yamaguchi, K. [1 ]
Mandai, M. [1 ]
Amano, Y. [1 ]
Kosaka, K. [1 ]
Matsumura, N. [1 ]
Baba, T. [1 ]
Yoshioka, Y. [1 ]
Hamanishi, J. [1 ]
Konishi, I [1 ]
机构：
[1] Kyoto Univ Shogoin, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, Kyoto, Japan
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2012年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [41] Sigma 1 Receptor Is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α
    Villemain, Laure
    Prigent, Sylvie
    Abou-Lovergne, Aurelie
    Pelletier, Laura
    Chiral, Magali
    Pontoglio, Marco
    Foufelle, Fabienne
    Caruso, Stefano
    Pineau, Raphael
    Rebouissou, Sandra
    Chevet, Eric
    Zucman-Rossi, Jessica
    Combettes, Laurent
    CANCERS, 2020, 12 (08) : 1 - 16
  • [42] Identification of target genes of the transcription factor HNF1β and HNF1α in a human embryonic kidney cell line
    Senkel, S
    Lucas, B
    Klein-Hitpass, L
    Ryffel, GU
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2005, 1731 (03): : 179 - 190
  • [43] SENSITIVITY TO CONVENTIONAL CHEMOTHERAPEUTIC DRUGS ACCORDING TO ARID1A DEFICIENCY OF OVARIAN CLEAR CELL CARCINOMA AND ENDOMETRIOID CARCINOMA CELLS
    Kuroda, T.
    Ogiwara, H.
    Takahashi, K.
    Sasaki, M.
    Yoshida, H.
    Kato, T.
    Okamoto, A.
    Kohno, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 180 - 180
  • [44] Low ARID1A Immunoexpression in Penile Squamous Cell Carcinoma
    Netto, G. J.
    Bezerra, S. M.
    Gonzalez-Roibon, N.
    Chaux, A.
    Munari, E.
    Ball, M.
    Shih, I-M
    Burnett, A. L.
    Faraj, S. F.
    MODERN PATHOLOGY, 2014, 27 : 252A - 252A
  • [45] Low ARID1A Immunoexpression in Penile Squamous Cell Carcinoma
    Netto, G. J.
    Bezerra, S. M.
    Gonzalez-Roibon, N.
    Chaux, A.
    Munari, E.
    Ball, M.
    Shih, I-M
    Burnett, A. L.
    Faraj, S. F.
    LABORATORY INVESTIGATION, 2014, 94 : 252A - 252A
  • [46] ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component (vol 67, pg 866, 2014)
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Shozu, M.
    HISTOPATHOLOGY, 2016, 68 (04) : 621 - 621
  • [47] Loss of ARID1A is a frequent event in clear cell and endometrioid ovarian cancers
    Lowery, W.
    Schildkraut, J.
    Akushevich, L.
    Bentley, R.
    Huntsman, D.
    Marks, J.
    Berchuck, A.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S21 - S21
  • [48] Synthetic lethal interaction between ARID1A mutation and BET bromodomain inhibition in ovarian clear cell carcinoma
    Berns, Katrien
    Caumanns, Joseph J.
    Hijmans, E. Marielle
    Gennissen, Annemiek
    Evers, Bastiaan
    Wisman, Bea A.
    Meersema, Gert Jan
    Lieftink, Cor
    Beijersbergen, Roderick L.
    Itamochi, Hiroaki
    van der Zee, Ate G.
    de Jong, Steven
    Bernards, Rene
    CANCER RESEARCH, 2017, 77
  • [49] SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
    Wagner, Samantha Kay
    Moon, Ashley S.
    Howitt, Brooke E.
    Renz, Malte
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 50
  • [50] A Comparison of CTH, HNF-1β, Napsin and ER as Markers for Endometrial Clear Cell Carcinoma and its Mimics
    Cochrane, Dawn
    Tessier-Cloutier, Basile
    Cheng, Angela S.
    Huntsman, David
    Gilks, C. Blake
    Hoang, Lien
    LABORATORY INVESTIGATION, 2018, 98 : 413 - 414
12345